FDA NDC Directory · JSON-LD · Markdown

VIJOICE

NDC 0078-1175 · HUMAN PRESCRIPTION DRUG · GRANULE

Generic namealpelisib
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryNew Drug Application (innovator) · App NDA218466
Dosage form / routeGRANULE · ORAL
Active ingredientsALPELISIB (50 mg/1)
Marketing started20240424
Package count1

External sources

Source: openFDA. Public-domain (CC0).